Post-approval studies (Phase 4)UnknownNCT02571842What this trial is testingRituximab in Recurrent IgA NephropathyWho this might be right forRecurrent IgA Nephropathy Chulalongkorn University 30
Post-approval studies (Phase 4)Ended earlyNCT02523768What this trial is testingPrevention in Recipients With Primary IgA Nephropathy of Recurrence After Kidney Transplantation: ATG-F Versus Basiliximab as Induction Immunosuppressive TreatmentWho this might be right forGlomerulonephritisIgAN Centre Hospitalier Universitaire de Saint Etienne 117